| A review of patient-reported outcome measures to assess female infertility-related quality of life H Kitchen, N Aldhouse, A Trigg, R Palencia, S Mitchell Health and quality of life outcomes 15, 1-12, 2017 | 60 | 2017 |
| A physician-completed digital tool for evaluating disease progression (multiple sclerosis progression discussion tool): validation study T Ziemssen, D Piani-Meier, B Bennett, C Johnson, K Tinsley, A Trigg, ... Journal of Medical Internet Research 22 (2), e16932, 2020 | 50 | 2020 |
| A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective L Humphrey, T Willgoss, A Trigg, S Meysner, M Kane, S Dickinson, ... Journal of patient-reported outcomes 1, 1-12, 2017 | 38 | 2017 |
| Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients K Sully, A Trigg, N Bonner, A Moreno‐Koehler, C Trennery, N Shah, ... European journal of haematology 103 (5), 500-509, 2019 | 33 | 2019 |
| Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study) P Moreau, S Kumar, R Boccia, S Iida, H Goldschmidt, K Cocks, A Trigg, ... Leukemia 33 (12), 2934-2946, 2019 | 28 | 2019 |
| A confirmatory factor analysis approach was found to accurately estimate the reliability of transition ratings P Griffiths, B Terluin, A Trigg, W Schuller, JB Bjorner Journal of Clinical Epidemiology 141, 36-45, 2022 | 27 | 2022 |
| Triangulation of multiple meaningful change thresholds for patient-reported outcome scores A Trigg, P Griffiths Quality of Life Research 30, 2755-2764, 2021 | 24 | 2021 |
| Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment JM Herman, H Kitchen, A Degboe, NVJ Aldhouse, A Trigg, M Hodgin, ... Quality of Life Research 28, 2929-2939, 2019 | 22 | 2019 |
| Patients’ lived experiences of nocturia: a qualitative study of the evening, the night, and the next day A Trigg, FL Andersson, NVJ Aldhouse, DL Bliwise, H Kitchen The Patient-Patient-Centered Outcomes Research 10, 711-718, 2017 | 14 | 2017 |
| Patient-reported outcomes (PRO) from the phase 2 CodeBreaK 100 trial evaluating sotorasib in KRAS p.G12C mutated non-small cell lung cancer (NSCLC). AI Spira, FH Wilson, G Shapiro, C Dooms, A Curioni-Fontecedro, T Esaki, ... Journal of Clinical Oncology 39 (15_suppl), 9057-9057, 2021 | 13 | 2021 |
| Patients’ experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study A Degboe, SL Knight, K Halling, A Trigg, T Al-Zubeidi, N Aldhouse, ... Journal of patient-reported outcomes 2 (1), 33, 2018 | 11 | 2018 |
| Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact … H Kitchen, C Seitz, A Trigg, N Aldhouse, T Willgoss, H Schmitz, A Gater, ... Health and quality of life outcomes 19, 1-14, 2021 | 9 | 2021 |
| Present state bias in transition ratings was accurately estimated in simulated and real data B Terluin, P Griffiths, A Trigg, CB Terwee, JB Bjorner Journal of Clinical Epidemiology 143, 128-136, 2022 | 8 | 2022 |
| Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel A Trigg, E Brohan, K Cocks, A Jones, AAT Monfared, I Chabot, G Meier, ... Epilepsy & Behavior 118, 107938, 2021 | 8 | 2021 |
| Health state utility valuation in patients with triple-class-exposed relapsed and refractory multiple myeloma treated with the bcma-directed car t cell therapy, idecabtagene … M Delforge, N Shah, P Rodriguez-Otero, P Hari, J Braverman, A Trigg, ... Blood 136, 14-15, 2020 | 8 | 2020 |
| A comparison of generic and condition-specific preference-based measures using data from nivolumab trials: EQ-5D-3L, mapping to the EQ-5D-5L, and European Organisation for … JW Shaw, B Bennett, A Trigg, M DeRosa, F Taylor, C Kiff, D Ntais, K Noon, ... Value in Health 24 (11), 1651-1659, 2021 | 7 | 2021 |
| Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps: data from the SYNAPSE study M Tabberer, A Trigg, W Busse, V Lund, J Lee, C Bachert, B Senior, ... Journal of Allergy and Clinical Immunology 147 (2), AB126, 2021 | 7 | 2021 |
| Establishing thresholds for meaningful within-individual change using longitudinal item response theory JB Bjorner, B Terluin, A Trigg, J Hu, KJS Brady, P Griffiths Quality of Life Research 32 (5), 1267-1276, 2023 | 6 | 2023 |
| Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric … W Fokkens, A Trigg, SE Lee, RH Chan, Z Diamant, C Hopkins, P Howarth, ... Journal of patient-reported outcomes 7 (1), 4, 2023 | 6 | 2023 |
| Mepolizumab improves health related quality of life for patients with chronic rhinosinusitis with nasal polyps: data from the SYNAPSE study S Lee, M Tabberer, A Trigg, J Han, W Fokkens, R Naclerio, P Gevaert, ... Journal of Allergy and Clinical Immunology 147 (2), AB125, 2021 | 6 | 2021 |
